Skip to main content

Table 3 Association between gout or hyperuricemia and dementia, different treatment/diagnosis groups

From: Hyperuricemia and dementia – a case-control study

Diagnosis (hyperuricemia or gout), Treatment regimen (antihyperuricemic drug use)a

Controls (n=110,112)

(% from 137,640)

Cases (n=27,528)

(% from 137,640)

OR (95% CI), adjusted

p-value, adjusted for covariates

D:0, T:0

81,091 (58.9)

20,204 (14.7)

Ref

 

D:0, T:1 < =qu < 4

2445 (1.8)

629 (0.5)

0.93 (0.85,1.02)

0.11

D:0, T:qu > =4

2084 (1.5)

558 (0.4)

0.95 (0.86,1.04)

0.26

D:1, T:0

10,385 (7.6)

2590 (1.9)

0.94 (0.89,0.98)

0.0065

D:1, T:1 < =qu < 4

4718 (3.4)

1168 (0.9)

0.89 (0.83,0.95)

< 0.001

D:1, T:qu > =4

9389 (6.8)

2379 (1.7)

0.89 (0.85,0.94)

< 0.001

  1. Global test: Wald Χ2 = 2403.13, DF = 14, p < 0.001
  2. aTreatment: T:0 means no anti-hyperuricemic treatment, qu > =x: means x or more quarters with treatment in the observation period, D:0 means no hyperuricamia diagnosis